Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


CARMA Therapeutics
3401 Grays Ferry Ave.
Philadelphia, PA 19146
https://carmatherapeutics.com/

CARMA Therapeutics is being built upon innovative technology from the Center for Cellular Immunotherapies at the University of Pennsylvania, and was spun out from the laboratory of Saar Gill, MD, PhD, assistant professor of Hematology Oncology in the Perelman School of Medicine at the University of Pennsylvania. "We hypothesized early on that focusing on different effector cells, other than T cells, might be more effective in trying to tackle solid tumors, which has been a challenge for T cell therapies. The innate biology drove us to try macrophages," says Dr. Gill, co-founder of CARMA Therapeutics, who conducts bench and clinical research on chimeric antigen receptor (CAR) T cells, and now on CAR macrophages.

Key Contact
NameTitleE-Mail
Bruce A. PeacockExecutive Chairman


Funding Events
DateAmountTypeInvestors
06/12/17undisclosedFirst Round AbbVie Biotech Ventures  
Grazia Equity
HealthCap  
IP Group
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.